Protagenic Therapeutics, Inc.new

Protagenic Therapeutics, Inc.new

Biotechnology Healthcare Santa Barbara, CA, United States PTIXW (NCM)

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.

Stock Performance (90 Days)

Data through Dec 24, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Biotechnology Companies

View All →

Frequently Asked Questions

Has Protagenic Therapeutics, Inc.new had layoffs?
No layoff events have been recorded for Protagenic Therapeutics, Inc.new in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
What industry is Protagenic Therapeutics, Inc.new in?
Protagenic Therapeutics, Inc.new operates in the Biotechnology industry, within the Healthcare sector.
Is Protagenic Therapeutics, Inc.new a publicly traded company?
Yes, Protagenic Therapeutics, Inc.new is publicly traded under the ticker symbol PTIXW on the NCM.
Where is Protagenic Therapeutics, Inc.new headquartered?
Protagenic Therapeutics, Inc.new is headquartered in Santa Barbara, CA, United States at 701 Anacapa Street, Santa Barbara, CA 93101, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.